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Abstract

Author Manuscript

(-)-Oleocanthal (OC), a phenolic compound present in extra-virgin olive oil (EVOO), has been
implicated in the health benefits associated with diets rich in EVOO. We investigated the effect of
OC on human cancer cell lines in culture and found that OC induced cell death in all cancer cells
examined as rapidly as 30 minutes after treatment in the absence of serum. OC treatment of nontransformed cells suppressed their proliferation but did not cause cell death. OC induced both
primary necrotic and apoptotic cell death via induction of lysosomal membrane permeabilization
(LMP). We provide evidence that OC promotes LMP by inhibiting acid sphingomyelinase (ASM)
activity, which destabilizes the interaction between proteins required for lysosomal membrane
stability. The data presented here indicate that cancer cells, which tend to have fragile lysosomal
membranes compared to non-cancerous cells, are susceptible to cell death induced by
lysosomotropic agents. Therefore, targeting lysosomal membrane stability represents a novel
approach for the induction of cancer-specific cell death.
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Introduction
Extra-virgin olive oil (EVOO), a central component of the Mediterranean diet, contains an
abundance of phenolic antioxidants that are potent inhibitors of reactive oxygen species and
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is associated with a reduced risk for several types of human cancer.1 Polyphenolic
secoiridoids of EVOO have been shown to decrease viability of HER2-overexpressing
breast cancer cells by selectively inducing apoptotic cell death.2 (-)-Oleocanthal (OC), a dialdehydic form of ligostride aglycone that has been isolated from EVOO, possesses a wide
range of biological effects. Previous studies have reported its activity as a potent
antioxidant; a non-steroidal anti-inflammatory agent that inhibits COX-1 and COX-2; a
neuroprotectant that alters the structure and function of the neurotoxins β-amyloid and Tau,
which are associated with the debilitating effects of Alzheimer disease; an inhibitor of
proliferation, migration, and invasion of human breast and prostate cancer cells through cMet inhibition; an inhibitor of AMPK in colon cancer cells; and an inhibitor of macrophage
inflammatory protein-1α in multiple myeloma.3-8
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To investigate the anticancer effects of OC, we examined its effect on the viability and
survival of cancerous and non-cancerous cells. Interestingly, OC rapidly (within 30 minutes)
induced loss of viability in cancer cells in a dose-dependent manner. Under serum
withdrawal, OC promoted primary necrotic cell death in cancer cells, which correlated with
elevated levels of phosphorylated ERK1/2 in the absence of cleaved caspase-3 expression.
In the presence of serum, a combination of apoptosis and secondary necrosis was observed.
Importantly, OC induced a reversible cell cycle arrest in non-cancerous cells but did not
affect their viability. Our findings indicate that OC-mediated cancer cell death is promoted
by destabilization of the lysosomal membrane, leading to the induction of lysosomal
membrane permeabilization (LMP). OC-induced LMP is mediated by the inhibition of acid
sphingomyelinase (ASM) activity, which can be derepressed by upregulation of Hsp70 or
dual treatment with anionic lipids. These data provide evidence that the anticancer benefits
of EVOO result, in part, from the ability of OC to rupture lysosomal membranes in cancer
cells leading to cell death via necrosis and/or apoptosis. Importantly, due to high lysosomal
membrane integrety, non-cancerous cells remain viable.
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Results
OC induces loss of cell viability in cancer cells but reversible cell cycle arrest in noncancerous cells
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OC has previously been shown to inhibit proliferation, migration, and invasion of breast and
prostate cancer cells via inhibition of c-Met phosphorylation.5 OC has also been reported to
inhibit cell proliferation in multiple myeloma cells via induction of apoptosis and inhibition
of macrophage inflammatory protein 1-α expression.7 To further explore the mechanism by
which OC induces cell death in cancer cells, we investigated the effect of OC on cell
viability in PC3 (prostate), MDA-MB-231 (breast), and BxPC3 (pancreatic) cancer cells.
Under serum withdrawal, 20 μM OC rapidly induced a loss of cell adhesion within 30 min
post treatment and resulted in 100% non-viability in all cancer cell lines after 24 h of
treatment (Fig. 1A). Interestingly, OC increased the levels of phosphorylated p44/42 (also
known as ERK1/ERK2), but did not significantly increase the levels of cleaved poly-ADPribose polymerase (PARP), an indicator of apoptotic death, in the absence of serum. It was
previously shown that ERK activation is a critical mediator of mitochondrial dysfunction
and necrotic cell death of renal epithelial cells following treatment with oxidizing agents.9
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Importantly, OC did not induce expression of cleaved caspase-3 in the absence of serum.
Caspase-3, an effector caspase necessary for the morphological and biochemical features
associated with apoptosis, is cleaved during both intrinsic and extrinsic apoptotic cell death
pathways.10, 11 The absence of cleaved caspase-3 expression upon OC treatment in the
absence of serum indicates that the cancer cells have bypassed the apoptotic machinery
leading to cell death. In addition, OC treatment resulted in a complete loss of mitochondrial
activity at low micromolar concentrations in the absence of serum, as measured by the MTT
assay (data not shown). Taken together, the rapid loss of viability caused by OC, together
with the absence of PARP and caspase-3 cleavage, suggests that OC induces primary
necrotic cell death in the absence of serum in a wide range of cancer cells.

Author Manuscript

In the presence of serum, however, OC treatment increased the levels of cleaved PARP and
cleaved caspase-3, which correlated with increased numbers of non-viable cells in all cancer
cell lines examined (Fig. 1B). OC did not have a significant effect on the level of
phosphorylated p44/42 in the presence of serum, when baseline levels of phosphorylated
p44/42 tended to be high (Fig. 1B), and only partially inhibited mitochondrial activity (data
not shown). Thus, in the presence of serum, OC induced cell death via activation of
apoptotic mechanisms. Overall, these data indicate that OC rapidly induces robust cancer
cell death via different mechanisms depending on whether serum is absent or present.
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Targeted cancer therapies that are cytotoxic to tumors and non-toxic to non-cancerous
tissues are in high demand but in short supply. Given that the data in Figs. 1A and 1B
demonstrate that OC significantly induces cell death in cancer cells, we examined the effect
of OC on non-cancerous BJ human fibroblasts, 3Y1 rat fibroblasts, and IMR90 human lung
fibroblasts. As shown in Fig. 1C, OC inhibited cell proliferation in all 3 non-cancerous cell
lines examined as determined by cell number after 72 h of treatment. Rapamycin was used
as a positive control because of its ability to induce G1 cell cycle arrest.12 Importantly, OC
did not induce PARP cleavage in the presence or absence of serum and cell proliferation was
restored after 72 h of OC treatment in BJ cells (Fig. 1D, upper and lower left panel).
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Phosphorylation of Rb is a critical step mediating progression through G1 to S phase of the
cell cycle.13 Underphosphorylation of Rb inhibits E2F activity through sequestration, thus
inhibiting cell cycle progression.14, 15 Rb phosphorylation at Ser608 is reported to be
necessary for reduced binding affinity of E2F to Rb.16 We therefore examined the effect of
OC on the levels of phospho-Rb at Ser608 in non-cancerous cells. As shown in Fig. 1D
(right panel), treatment of non-cancerous BJ and 3Y1 cells with OC resulted in decreased
levels of phospho-Rb at Ser608 after 24 h, which continued for 72 h in the presence of
serum. IMR90 cells did not show a significant decrease in Rb phosphorylation at Ser 608,
probably reflecting cell cycle arrest outside of G1.17 These data suggest that OC treatment
does not induce cell death in non-cancerous cells but rather reversibly induces cell cycle
arrest via suppression of Rb phosphorylation, which serves to protect healthy cells against
the adverse effects of OC.
OC differentially induces cell death in cancer cells in the absence and presence of serum
The morphological and biochemical changes associated with apoptotic cell death occur
between 6 and 12 h after a traumatic event that leads to apoptotic body formation between
Mol Cell Oncol. Author manuscript; available in PMC 2015 September 14.
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24 and 48 h.18 The rapidity with which OC induces cell rounding and loss of substrate
adherence in the absence of serum (observed within 30 min post treatment) suggests a nonapoptotic form of cell death. As shown in Fig. 1A, 20 μM OC induced elevated ERK1/2
phosphorylation, which has been associated with necrotic cell death,9 in the absence of
cleaved PARP and cleaved caspase-3 expression. We therefore investigated the method by
which OC induces cell death in the absence of serum using a cell death-specific assay kit
that distinguishes apoptosis from necrosis. A lower concentration of OC (10 μM) was used
for this assay to reduce the rate of cell rounding in order to determine the specific method of
cell death. As shown in Fig. 2A, OC induced a significant number of necrotic cells after 24 h
of treatment. The large number of necrotic cells observed explains the substantial decrease
in cell viability in the absence of cleaved caspase-3 and limited increase in cleaved PARP
(shown in Fig. 1A). Although PARP cleavage was not observed in the absence of serum due
to activation of the primary necrotic cell death pathway, increased levels of cleaved PARP
and caspase-3 were observed upon OC treatment in the presence of serum (Fig. 1B), which
resulted in more apoptotic than necrotic cells (Fig. 2B). Signaling pathways that regulate cell
death participate in both apoptosis and necrosis; thus, it is possible to have apoptotic and
secondary necrotic cell death within the same cell population.19,20 Collectively, data in Figs.
1 and 2 suggest that OC induces cell death in cancer cells via both apoptotic and necrotic
mechanisms depending on the presence or absence of serum.
OC downregulates ASM activity to induce LMP and cell death in cancer cells that is
reversed by anionic lipids

Author Manuscript

Primary necrosis caused by a severe insult, either extracellular or intracellular, can be
identified by rapid permeabilization of the plasma membrane.19 Lysosomes have recently
been implicated in cell death through the release of lysosomal hydrolytic enzymes into the
cytosol, which leads to apoptosis (via mitochondrial outer membrane permeabilization
[MOMP] and caspase activation) or necrosis (via cytosolic acidification).21 To determine
whether LMP mediates OC-induced cancer cell death, we examined the integrity of the
lysosomal membrane after OC treatment using acridine orange, a lysosomotropic
metachromatic fluorochrome that emits a red fluorescence when in present at a high
concentration within intact lysosomes.22 OC significantly reduced the red fluorescence in
both the absence and presence of serum, indicating that OC-induced cell death is mediated
by the induction of LMP in all cancer cell lines and conditions (Fig. 3A). However, OC did
not reduce the red fluorescence in the absence or presence of serum in BJ cells, indicating
that OC does not induce LMP in these non-cancerous cells (Fig. 3A lowest panel).

Author Manuscript

Lysosomal membrane integrity is regulated by the activity of ASM, a lysosomal lipase
responsible for the hydrolysis of sphingomyelin (SM) to ceramide.23 Petersen et al. have
shown that siramesine, a cationic amphiphilic drug, induces LMP as a result of inhibition of
ASM activity.24 We therefore examined the effect of OC on the activity of ASM. As shown
in Fig. 3B (left graph), under serum withdrawal conditions ASM activity was inhibited up to
40% following treatment with 10 μM OC for 4 h. In the presence of serum, 10 μM OC
induced a maximum 10% inhibition of ASM activity (Fig. 3B, right panel). The degree by
which ASM activity is inhibited correlates with the specific cell death pathway that is
activated upon OC treatment and the extent of LMP; massive or complete LMP rapidly
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liberates proteases from the lysosomes and has been shown to induce necrotic cell death,
whereas partial or selective LMP liberates proteases from the lysosome in a manner that
activates programmed apoptotic cell death.25, 26 These findings reveal a correlation between
OC-induced necrotic or apoptotic cell death and the level of ASM activity.

Author Manuscript
Author Manuscript

ASM activity is regulated by its ability to bind to bis (monoacylglycero)phosphate (BMP),
an anionic lipid that is an essential co-factor for lysosomal sphingomyelin metabolism.27
Hsp70 has been shown to bind with high affinity and specificity to BMP, thereby enhancing
the stability of the BMP–ASM complex, which in turn inhibits LMP and promotes cell
survival.23 Therefore, we examined whether Hsp70 inhibits OC-induced LMP. Cerulenin, a
fatty acid synthase inhibitor, has been shown to upregulate Hsp70 expression through the
ability of Hsp70 to interact directly with fatty acids.28 Under serum withdrawal conditions,
cerulenin-mediated overexpression of Hsp70 partially inhibited OC-induced LMP in PC3
cancer cells (Fig. 3C). Cationic lipids or cationic amphiphilic drugs have been shown to
destabilize the lysosomal membrane by inhibiting the hydrolysis of SM via downregulation
of ASM activity.24,29 However, anionic amphipathic lipids or free fatty acids have been
shown to enhance ASM activity.30–32 We therefore examined the effect of an anionic lipid
mixture on OC-induced LMP. As shown in Fig. 3D (left panel), treatment with anionic
lipids inhibited OC-induced LMP in PC3 cells in the absence of serum. The inhibition of
OC-induced LMP also correlated with an increase in cell viability as measured by the
percentage of attached cells Fig. 3D (right panel). Dual treatment with lipids and OC did not
result in cell death, as observed by the lack of floating cells after 24 to 72 h of OC treatment,
although there was a decrease in cell proliferation. These data indicate that maintaining or
enhancing ASM activity through the addition of anionic lipids increases the stability of the
lysosomal membrane, thus preventing LMP-induced cell death in cancer cells. Collectively,
the data in Figs. 1–3 indicate that OC inhibits ASM activity in cancer cells, leading to
complete or partial LMP and resulting in necrotic or apoptotic cell death in the absence and
presence of serum, respectively.

Discussion
The data presented here demonstrate that OC selectively induces cell death in cancer cells
via downregulation of ASM activity leading to LMP, while reversibly arresting noncancerous cells. In non-cancerous cells, OC induces G1 cell cycle arrest via inhibition of Rb
phosphorylation at Ser608, preventing cell cycle progression into S phase.33,34 Importantly,
non-cancerous cells that are arrested by OC resume proliferation after 72 h of OC treatment.
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In contrast to the cell cycle arrest observed in non-cancerous cells, cancer cells rapidly
underwent either primary necrotic cell death under serum withdrawal conditions, correlating
with increased ERK1/2 phosphorylation in the absence of cleaved caspase-3 and PARP, or
caspase-3–dependent apoptotic cell death in the presence of serum via induction of LMP.
During the development of cancer cells, lysosomes undergo morphological transformation
that leads to increased size and greater cathepsin activity compared with those in normal
cells.35 The increased lysosomal size renders cancer cells vulnerable to treatment with
anticancer agents.36 LMP causes a release of cathepsins (lysosomal proteases) into the
cytosol leading to degradation of cellular proteins.21 Accordingly, the amount and rate of
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lysosomal enzyme release into the cytosol mediates the activation of necrotic or apoptotic
signaling pathways.26 We have shown here that the degree of OC-mediated suppression of
ASM activity correlates with activation of specific cell death pathways.
Although fragility of the lysosomal membrane increases the susceptibility of cancer cells to
LMP, cells can overcome this vulnerability by overexpressing Hsp70, a regulator of
multiprotein complex assembly and protein transport across cellular membranes.37 Hsp70
localizes on the lysosomal membrane and protects against LMP by enhancing ASM activity
and stabilizing the interaction between ASM and BMP.23,35 Therefore, overexpression of
Hsp70 in cancer cells favors cell survival by increasing lysosomal integrity and preventing
LMP.35,37 Increasing Hsp70 expression with cerulenin, a fatty acid synthesis inhibitor,
suppresses OC-induced LMP in PC3 cells due to increased lysosomal membrane stability.28
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Whereas cationic lipids destabilize the lysosomal membrane by regulating the interaction
between ASM and the lysosomal membrane, anionic lipids such as BMP and
phosphatidylinositol (PI) have been shown to activate ASM activity as measured by
enhanced hydrolysis of SM.29,31,32 We have provided evidence that anionic free fatty acids
are also capable of stabilizing the lysosomal membrane and preventing LMP. Our findings
suggest that OC-mediated cancer cell death is due to its ability to act as a lysosomotropic
agent and facilitate complete LMP in the absence of serum and partial LMP in the presence
of serum, which is related to the rate of ASM activity inhibition.

Author Manuscript

Importantly, it was recently reported that OC prevents tumor growth in an orthotopic model
of breast cancer in athymic nude mice.38 This study presented data implicating suppression
of c-Met as a critical consequence of OC treatment although it was not clear whether LMP
was involved in cell death or PARP cleavage was observed. Nonetheless, the study
demonstrated that OC has similar effects in an animal model to those described in the
current study with minimal effects on normal cells, thus reinforcing the potential of OC as a
therapeutic agent in breast and other cancers.

Author Manuscript

Our study provides a mechanism by which OC selectively and rapidly induces cell death in
cancer cells without being cytotoxic to non-cancerous cells. Compounds that induce
lysosomal membrane destabilization, such as OC, represent a viable method to exploit the
vulnerability of the enlarged lysosomes in cancer cells. Our data suggest that the
chemopreventive activity of EVOO is due to the ability of its bioactive phenolic
components, especially OC, to induce cell death by entering the lysosome and inhibiting
ASM activity, which induces LMP. Therefore, the ability of OC to induce LMP in cancer
cells, but not normal cells, represents a novel therapeutic strategy for treating a large number
of cancer types in which lysosomes are enlarged and more sensitive to lysosomotropic
agents.

Materials and methods
Cells and cell culture conditions
The BxPC3, PC3, MDA-MB-231, BJ, 3Y1, and IMR90 cells used in this study were
obtained from the American Type Tissue Culture Collection and were maintained in
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Roswell Park Memorial Institute Medium (RPMI) and Dulbecco's Modified Eagle Medium
(DMEM), respectively, supplemented with 10% or 15% (IMR90) fetal bovine serum
(Hyclone). No authentication was performed by the authors.

Lipid mix supplementation

Rapamycin was obtained from LC Labs. (-)-OC, extracted from EVOO, was obtained from
Dr. Alexios-Leandros Skaltsounis at the University of Athens Department of Pharmacology.
The structure and purity (97%) of (-)-oleocanthal was determined by HPLC and 1H-NMR
analysis. Acridine orange was obtained from Life Technologies. The Promokine Apoptotic/
Necrotic/Healthy cell detection kit and Cerulenin were obtained from Fisher Scientific. The
Sphingomyelinase Fluorometric Assay kit was obtained from Cayman Chemicals. Primary
antibodies specific for cleaved caspase-3, cleaved PARP, phospho-p44/42 (Thr202/Tyr204),
total p44/42, β-actin, and phospho-Rb (Ser 608) were obtained from Cell Signaling
Technology. Antibodies against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
Hsp70 were obtained from Santa Cruz Biotechnology.

Fatty acid mixture was obtained from Invitrogen (11905) and was supplied to cells as a
1:200 dilution complexed with 5% fatty acid free bovine serum albumin (BSA; Sigma
Aldrich) in a 2:1 ratio for a final lipid concentration in the media of 0.375 mg/L. The
composition of the fatty acid mixture was arachidonic acid (20:4; 2 mg/L), cholesterol (220
mg/L), DL-α-Tocophenol acetate (70 mg/L), linoleic acid (18:2; 10 mg/L), linolenic acid
(18:3; 10 mg/L), myristic acid (14:0; 10 mg/L), oleic acid (18:1; 10 mg/L), palmitic acid
(16:0; 10 mg/L), puronic F-68 (90,000 mg/L), stearic acid (18:0; 10 mg/L), Tween 80 (2,200
mg/L).

Author Manuscript

Cell viability and proliferation, acid sphingomyelinase activity, apoptosis/necrosis cell
assay
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Cell viability was determined by the level of mitochondrial activity using the MTT (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay according to the vendor's
instructions (Sigma Aldrich). Cell proliferation and percentage of non-viable cells were
determined by calculating the percentage of attached cells compared to control as previously
described.39 ASM activity was determined using the Sphingomyelinase Fluorometric Assay
kit from Cayman Chemicals. Cell death was evaluated by 2 separate methods: examination
of cleavage of the caspase-3 substrate PARP and detection of apoptotic, necrotic, and
healthy cells by the Promokine Apoptotic/Necrotic/Healthy Cells Detection Kit following
the manufacturer's guidelines. Briefly, by using a combination of Annexin V, ethidium
homodimer III, and Hoechst 33342, apoptotic, necrotic, and healthy cells can be respectively
quantified within the same cell population. Healthy cells are only stained by membrane
permeable Hoechst 33342, with blue fluorescence. Apoptotic cells exhibit Annexin V green
staining. Ethidium homodimer III, which is impermeant to live or apoptotic cells, stains
necrotic cells intensely with red fluorescence. Cells entering late apoptosis (also known as
secondary necrosis) are stained both green and blue.
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Immunostaining for the cell death assay or lysosomal integrity was performed in a cell
suspension. For the cell death assay, cells were incubated with FITC-Annexin V, ethidium
Homodimer III, and Hoechst 33342, washed twice with a 1× Binding Buffer, and then
resuspended in 30 μL 1× Binding Buffer. For the lysosomal integrity assay, cells were
washed twice with PBS and then resuspended in 30 μL PBS. A 5-μL sample of the cell
suspension was placed on a microscope slide and covered with a coverslip. Images were
collected with an Olympus BX61 fluorescence microscope with a 10× objective, connected
to a Hamamatsu ORCA-ER CCD camera and controlled by the SlideBook 5.1 image capture
software.
Western blot analysis
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Proteins were extracted from cultured cells in modified RIPA buffer (Upstate
Biotechnology). Equal amounts of protein were separated by SDS-PAGE, transferred to
nitrocellulose, and subjected to western blot analysis as described previously.40 Western
blots were quantified using ImageJ software.
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extra virgin olive oil

LMP

lysosomal membrane permeabilization

OC

-(-)Oleocanthal

PARP

poly(ADP-ribose) polymerase
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Figure 1.
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OC induces loss of cell viability in cancer cells but reversible cell cycle arrest in noncancerous cells. (A, B) PC3, MDA-MB-231, and BxPC3 cells were plated at a density of 3 ×
105 cells/35-mm plate. After 24 h the medium was replaced with fresh medium containing
0% serum (A) or 10% serum (B) and the indicated concentration of OC. After incubation for
4 h, levels of cleaved PARP, phospho-p44/42 (Thr202/Tyr204), total p44/42, cleaved
caspase 3, and GAPDH were determined. Cell viability was determined after 24 h of
treatment. (C) BJ, 3Y1, and IMR90 cells were plated at a density of 5 × 104 cells/35-mm
plate. After 24 h the cells were provided with fresh media containing 10% serum and the
indicated concentration of OC or rapamycin (Rapa). After incubation for 24, 48, or 72 h the
attached cells were counted to determine cell proliferation. (D) (Upper left panel) BJ cells
were plated at a density of 2 × 105 cells/35-mm plate. After 24 h the cells were provided
with fresh media containing 10% serum and the indicated concentration of OC. After
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incubation for 4 h, levels of cleaved PARP, phospho-p44/42 (Thr202/Tyr204), and GAPDH
were determined. (Lower left panel) BJ cells were plated at a density of 5 × 104 cells/35-mm
plate. After 24 h the cells were provided with fresh media containing 10% serum and the
indicated concentration of OC or Rapa. After a further 24, 48, 72, 96, or 120 h, the cells
were counted to determine cell proliferation. (Right panel) BJ, 3Y1, and IMR90 cells were
plated as above. After 24 h the cells were provided with fresh media containing 10% serum
and the indicated concentration of OC or Rapa. After a further 24, 48, or 72 h, the cells were
subjected to western blot analysis for phosphorylated Rb (Ser608) and GAPDH or β-actin.
Error bars for all graphs represent the standard deviation from two independent experiments.
All data shown are representative of at least two independent experiments.

Author Manuscript
Author Manuscript
Author Manuscript
Mol Cell Oncol. Author manuscript; available in PMC 2015 September 14.

LeGendre et al.

Page 14

Author Manuscript
Author Manuscript
Author Manuscript

Figure 2.
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OC differentially induces cell death in cancer cells in the absence and presence of serum.
(A) PC3, MDA-MB-231, and BxPC3 cells were plated at a density of 2 × 105 cells/60-mm
plate. After 24 h the cells were provided with fresh media containing 0% serum and 10 μM
OC as indicated. After a further 24 h the cells were subjected to the Apoptosis/Necrosis/
Healthy cell assay and analyzed by fluorescence microscopy using FITC, Texas Red, and
DAPI filter settings. (B) PC3, MDA-MB-231, and BxPC3 cells were plated as above. After
24 h the cells were provided with fresh media containing 10% serum and 10 μM OC as
indicated. After a further 24 h, the cells were analyzed using the Apoptosis/Necrosis/Healthy
cell assay kit as above. Cell numbers were determined using the ImageJ cell counter. Data
shown are representative of at least two independent experiments. Scale bars = 200 μm.
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Figure 3.
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OC downregulates ASM activity to induce LMP and cell death in cancer cells that is
reversed by anionic lipids. (A) PC3, MDA-MB-231, BxPC3, and BJ cells were plated at a
density of 3 × 105 cells/60-mm plate. After 24 h the cells were provided with fresh media
containing 0 or 10% serum and 10 μM OC as indicated. After a further 4 h the cells were
treated with 5 μM acridine orange for 15 min and then subjected to fluorescence microscopy
using a Texas Red filter setting. (B) PC3, MDA-MB-231, and BxPC3 cells were plated at a
density of 5 × 106 cells/10-cm plate. After 24 h the cells were provided with fresh media
containing 0 or 10% serum and 10 μM OC as indicated. Acid sphingomyelinase activity was
measured after a further 4 h. (C) PC3 cells were plated at a density of 2 × 105 cells/60-mm
plate. After 24 h the cells were provided with fresh media containing 10% serum and 30 μM
cerulenin as indicated. After a further 24 h, the cells were provided with fresh media
containing 0% serum and 10 μM OC as indicated and incubated for 4 h. The cells were
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treated with 5 μM acridine orange for 15 min and subjected to fluorescence microscopy
using a Texas Red filter setting or western blot analysis of Hsp70 and GAPDH. (D) PC3
cells were plated at a density of 2 × 105 cells/60-mm plate. After 24 h the cells were
provided with fresh media containing 0% serum, 10 μM OC, and lipids as indicated. After 4
or 24 h the cells were treated with 5 μM acridine orange for 15 min and subjected to
fluorescence microscopy using a Texas Red filter setting. Cell viability was determined after
24 h. ImageJ software was used to quantify the western blots. Experiments shown are
representative of at least two independent experiments. Scale bars = 200 μm.
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